Myozyme and cardiac arrest 
Myozyme and cardiac arrest Patient Reports February 13, 2012
Myozyme Side Effects Report #5226776-1
Myozyme side effect was reported by a Physician from NETHERLANDS on Jan 15, 2007. Female patient, child 8 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, bradycardia, bronchospasm, cardiac arrest
, gastroenteritis , infusion related reaction, oedema. Myozyme dosage: unknown. During the same period patient was treated with ZYRTEC, HYDROCORTISONE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5237944-7
Myozyme side effect was reported by a Physician from NETHERLANDS on Jan 29, 2007. Female patient, child 8 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, bronchospasm, cardiac arrest
, erythema, gastroenteritis , infusion related reaction, oedema peripheral, rash , vasoconstriction. Myozyme dosage: 40 MG/KG QWK IV. During the same period patient was treated with ZYRTEC, HYDROCORTISONE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5255123-4
Myozyme side effect was reported by a Physician from NETHERLANDS on Feb 14, 2007. Female patient, child 8 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, autonomic nervous system imbalance, blood immunoglobulin e increased, bradycardia, bronchospasm, cardiac arrest
, eosinophilia, erythema, gastroenteritis . Myozyme dosage: 40 MG/KG QWK IV. During the same period patient was treated with ZYRTEC, HYDROCORTISONE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5480221-X
Myozyme side effect was reported by a Physician from CANADA on Sept 19, 2007. Male patient, child 8 years of age, weighting 61.95 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, immobile, post procedural complication, procedural pain. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5633193-9
Myozyme side effect was reported by a Physician from FRANCE on Feb 01, 2008. Female patient, 74 years of age, weighting 177.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, bundle branch block left, cardiac arrest
, dysarthria, fall , lung disorder, meningioma, muscular weakness, musculoskeletal disorder. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5925448-5
Myozyme side effect was reported by a Physician from FRANCE on Oct 08, 2008. Female patient, 74 years of age, weighting 177.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, cardiac arrest
, dysarthria, electrocardiogram st segment elevation, fall , lung disorder, malaise, meningioma, meningorrhagia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS : 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5326886-4
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Apr 28, 2007. Female patient, child 4 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, cyanosis, device malfunction, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient died on 04/28/2007.Myozyme Side Effects Report #6065653-3
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 22, 2009. Female patient, child 4 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: atelectasis, blood immunoglobulin g increased, cardiac arrest
, escherichia urinary tract infection, hypokalaemia, hypoxia, impaired gastric emptying, leukopenia, lobar pneumonia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PNEUMOCOCCAL CONJUGATE VACCINE. Patient recovered.Myozyme Side Effects Report #5409633-7
Myozyme side effect was reported by a Physician from UNITED STATES on July 30, 2007. Male patient, child 3 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: arrhythmia
, cardiac arrest , disease progression, glycogen storage disease type ii. Myozyme dosage: 40 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient was hospitalized. Patient died on 07/26/2007.Myozyme Side Effects Report #5887098-9
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 03, 2008. Female patient, child 3 years of age, weighting 24.03 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest
, hypoxia, impaired gastric emptying, nausea , occult blood positive, respiratory failure, upper gastrointestinal haemorrhage. Myozyme dosage: 138 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5483158-5
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 25, 2007. Female patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest
, infusion related reaction, mechanical ventilation, myocardial ischaemia, nausea , oxygen saturation decreased, regurgitation, respiratory failure. Myozyme dosage: unknown. Patient recovered.Myozyme Side Effects Report #5747235-3
Myozyme side effect was reported by a Physician from UNITED ARAB EMIRATES on May 04, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, no therapeutic response, ventricular tachycardia. Myozyme dosage: unknown. During the same period patient was treated with SALBUTAMOL, FLUTICASONE, BI PAP. Patient died on 04/15/2008.Myozyme Side Effects Report #5757715-2
Myozyme side effect was reported by a Physician from UNITED ARAB EMIRATES on May 04, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, ventricular tachycardia. Myozyme dosage: unknown. During the same period patient was treated with SALBUTAMOL, FLUTICASONE, BI PAP. Patient died on 04/15/2008.Myozyme Side Effects Report #5831700-4
Myozyme side effect was reported by a Physician from UNITED ARAB EMIRATES on July 15, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, no therapeutic response, ventricular tachycardia. Myozyme dosage: unknown. During the same period patient was treated with SALBUTAMOL, FLUTICASONE, BI PAP, ANTIBIOTICS. Patient died on 04/15/2008.Myozyme Side Effects Report #5676851-2
Myozyme side effect was reported by a Physician from CANADA on Mar 05, 2008. Male patient, child 10 years of age, weighting 62.83 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, osteonecrosis , post procedural complication, pyrexia, tooth extraction. Myozyme dosage: 20 MG/KG, Q2W. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5229469-X
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 17, 2007. Male patient, weighting 15.21 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, cardiac arrest
, infection , pyrexia, respiratory distress, tachycardia, wheezing. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN, POTASSIUM CHLORIDE, FAMOTIDINE, DIGOXIN, PROPRANOLOL, FUROSEMIDE, HYDROCHLOROTHIAZIDE. Patient recovered.Myozyme Side Effects Report #5244242-4
Myozyme side effect was reported by a Physician from TURKEY on Feb 02, 2007. Male patient, weighting 24.25 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
. Myozyme dosage: 20 MG/KG Q2WKS; IV. Patient was hospitalized. Patient died on 01/18/2007.Myozyme Side Effects Report #5286975-X
Myozyme side effect was reported by a Physician from BRAZIL on Mar 14, 2007. Male patient, weighting 22.05 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: atelectasis, cardiac arrest
, hypertrophic cardiomyopathy, mitral valve incompetence, pneumonia , rhinorrhoea. Myozyme dosage: 20 MG/KG, Q2WKS; IV. During the same period patient was treated with ALPHA. Patient died on 03/14/2007.Myozyme Side Effects Report #5148156-X
Myozyme side effect was reported by a Physician from BRAZIL on Oct 23, 2006. Male patient, weighting 16.53 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest
, cardiac failure, condition aggravated, heart rate increased, pneumonia , respiratory rate increased, shock, ventricular fibrillation. Myozyme dosage: 20 MG/KG ONCE IV. During the same period patient was treated with CAPTOPRIL, FUROSEMIDE. Patient died on 10/23/2006.Myozyme Side Effects Report #5165813-X
Myozyme side effect was reported by a Physician from BRAZIL on Nov 14, 2006. Male patient, weighting 10.80 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, hypertonia, respiratory arrest. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with CAPTOPRIL, PROPRANOLOL. Patient died on 11/13/2006.Myozyme Side Effects Report #5196520-5
Myozyme side effect was reported by a Consumer or non-health professional from GERMANY on Dec 08, 2006. Female patient, weighting 22.05 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, atelectasis, cardiac arrest
, cardiac failure congestive, cardiac ventricular disorder, pleural effusion, respiratory disorder. Myozyme dosage: 20 MG/KG QOW IV. During the same period patient was treated with ALPHA. Patient was hospitalized. Patient died on 12/06/2006.Myozyme Side Effects Report #5448551-5
Myozyme side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Male patient, weighting 13.85 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
. Myozyme dosage: 20 MG Q2WKS IV. Patient died on 08/22/2007.Myozyme Side Effects Report #5463811-X
Myozyme side effect was reported by a Health Professional from UNITED STATES on Sept 05, 2007. Male patient, weighting 13.85 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, disease recurrence. Myozyme dosage: 50 MG ONCE IV. During the same period patient was treated with FENTANYL, PROPRANOLOL, PULMICORT, BUDESONIDE, MIRLAX, TIMENTIN. Patient was hospitalized. Patient died on 08/22/2007.Myozyme Side Effects Report #5490291-0
Myozyme side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2007. Male patient, weighting 13.85 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, cough, fluid overload, hepatomegaly, respiratory failure, wheezing. Myozyme dosage: 50 MG ONCE IV. During the same period patient was treated with FENTANYL, PROPRANOLOL, PULMICORT, BUDESONIDE, MIRLAX, TIMENTIN. Patient was hospitalized. Patient died on 08/22/2007.Myozyme Side Effects Report #5579302-1
Myozyme side effect was reported by a Physician from UNITED STATES on Dec 14, 2007. Female patient, weighting 7.72 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, hypoperfusion. Myozyme dosage: 20 MG/KG, ONCE, INTRAVENOUS. Patient was hospitalized. Patient died on 12/16/2007.Myozyme Side Effects Report #5586084-6
Myozyme side effect was reported by a Health Professional from UNITED STATES on Dec 27, 2007. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest
, catheter related infection, hypoxic encephalopathy, influenza, infusion related reaction, respiratory distress, respiratory failure, sepsis . Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 12/21/2007.Myozyme Side Effects Report #5587783-2
Myozyme side effect was reported by a Physician from UNITED STATES on Dec 27, 2007. Female patient, weighting 7.72 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest
, hypoperfusion, pyrexia. Myozyme dosage: 20 MG/KG, ONCE, INTRAVENOUS. During the same period patient was treated with MILRINONE, FENTANYL, DOPAMINE, ESMOLOL, EPINEPHRINE, PANCURONIUM, FUROSEMIDE, VANCOMYCIN. Patient was hospitalized. Patient died on 12/16/2007.Myozyme Side Effects Report #5657647-4
Myozyme side effect was reported by a Physician from GERMANY on Feb 19, 2008. Female patient, weighting 13.01 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, cardiac failure, cardiomegaly, oedema, pneumonia , procedural complication, pyelonephritis, tachycardia, ventricular hypertrophy. Myozyme dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient died on 01/06/2008.Myozyme Side Effects Report #5679713-X
Myozyme side effect was reported by a Physician from BRAZIL on Mar 07, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: brain hypoxia, cardiac arrest
, circulatory collapse, convulsion, cyanosis, diarrhoea. Myozyme dosage: 20 MG/KG, Q2W. During the same period patient was treated with CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 03/06/2008.Myozyme Side Effects Report #5679717-7
Myozyme side effect was reported by a Physician from BRAZIL on Mar 07, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: brain hypoxia, cardiac arrest
, circulatory collapse, convulsion, cyanosis, diarrhoea, haemodynamic instability. Myozyme dosage: 20 MG/KG, Q2W. During the same period patient was treated with CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 03/06/2008.Myozyme Side Effects Report #5850894-8
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Aug 04, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, cardiopulmonary failure, pyrexia, sepsis . Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died.Myozyme Side Effects Report #5871196-X
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Aug 15, 2008. Male patient, weighting 13.23 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, cardiac failure, condition aggravated, culture urine positive, hypertrophic cardiomyopathy, hypotonia, hypoxia, oxygen consumption increased, pyrexia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient died on 05/15/2006.Myozyme Side Effects Report #5885628-4
Myozyme side effect was reported by a Physician from CHINA on Sept 08, 2008. Female patient, weighting 13.89 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: acinetobacter infection, alpha haemolytic streptococcal infection, aspiration tracheal abnormal, blood immunoglobulin g increased, blood sodium decreased, cardiac arrest
, cardiac failure, condition aggravated, disease recurrence. Myozyme dosage: 20 MG/KG, Q2W; INTRAVENOUS. During the same period patient was treated with MILRINONE. Patient was hospitalized. Patient died on 09/06/2008.Myozyme Side Effects Report #6043378-8
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 07, 2009. Female patient, weighting 11.46 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, respiratory failure. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS. During the same period patient was treated with NYSTATIN, LASIX, OXYGEN. Patient died on 01/06/2009.Myozyme Side Effects Report #6057977-0
Myozyme side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2009. Female patient, weighting 11.46 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, asthenia, cardiac arrest
, respiratory failure. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS. During the same period patient was treated with NYSTATIN, LASIX. Patient died on 01/06/2009.